Ocumetics Technology Corp. (OTCFF)
| Market Cap | 50.56M +73.0% |
| Revenue (ttm) | n/a |
| Net Income | -3.05M |
| EPS | -0.03 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 8,664 |
| Open | 0.4006 |
| Previous Close | 0.4006 |
| Day's Range | 0.4006 - 0.4006 |
| 52-Week Range | 0.1872 - 1.4000 |
| Beta | 0.50 |
| RSI | 36.09 |
| Earnings Date | Apr 10, 2026 |
About Ocumetics Technology
Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. The company develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed changed its name to Ocumetics Technology Corp. in August 2021. Ocumetics Technology Corp. was founded in 2012 and is headquartered in Calgary, Canada. [Read more]
News
Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update
Calgary, Alberta – February 10, 2026 – TheNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce that the Corporatio...
Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology
Key Highlights Positive First-in-Human Results: Three-month Group 1 data met or exceeded expectations for safety, lens delivery, and vision performance.
Ocumetics Announces Proposed Forbearance Agreement for $4 million Secured Convertible Debentures
Calgary, Alberta – January 30, 2026 – TheNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it is seeking approval from ...
Ocumetics Announces Transition of Chief Medical Officer Consulting Role
Calgary, Alberta – TheNewswire - January 9, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology,...
Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital
Calgary, AB – TheNewswire - January 2, 2026 – Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QB0) is pleased to announce that it has closed the fir...
Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital
Calgary, AB – TheNewswire - December 19, 2025 – Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QB0) announces that further to its previously announ...
Ocumetics Announces Optimized Lens Delivery System in Collaboration with Medicel
Calgary, Alberta – TheNewswire - December 9, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology...
Ocumetics Technology Announces $2.5 Million Brokered LIFE Offering Led by Centurion One Capital
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Calgary, AB – TheNewswire - November 25, 2025 – Ocumetics Technology Corp. (“ Ocumetics ” or the “ C...
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations
Calgary, Alberta – TheNewswire - November 5, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology...
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations
Calgary, Alberta – TheNewswire - November 5, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology...
Ocumetics to Present at the Centurion One Capital 3rd Annual Bahamas Summit
Calgary, Alberta – TheNewswire - October 24, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pl...
Ocumetics To Participate in the 2025 Maxim Growth Summit
Calgary, Alberta – October 21, 2025 – TheNewswire - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pl...
Ocumetics Announces Issuance of Stock Options
Calgary, Alberta – TheNewswire - October 15, 2025. Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ”) announces that it has issued 732,000 incentive stock options...
Ocumetics Webinar - Discussion of One-Month Postoperative Patient Results
Calgary, Alberta – TheNewswire - October 14, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pl...
Ocumetics Reports Encouraging One-Month Postoperative Results
Calgary, Alberta – TheNewswire - October 8, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is ple...
Ocumetics Reports Second Successful Surgery Day
Calgary, Alberta – TheNewswire - September 26, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is ...
Ocumetics Completes One-Month Postoperative Examinations - Results Pending
Calgary, Alberta – TheNewswire - September 16, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is ...
Ocumetics Engages The Howard Group to Direct Capital Market & Corporate Digital Communications Programs
Calgary, Alberta – September 12, 2025 – TheNewswire - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), is pleased to announce that it has engaged Howa...
Ocumetics Webinar - Accommodating Intraocular Lens Update
Calgary, Alberta – August 27, 2025 – TheNewswire - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is ple...
Ocumetics Prepares for a Second Day of Accommodating Intraocular Lens Implantations
Calgary, Alberta – TheNewswire - August 26, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is ple...
Ocumetics Achieves Historic First: Accommodating Intraocular Lens Successfully Implanted in Human Patients
Calgary, Alberta – TheNewswire - August 18, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is ple...
Ocumetics Achieves Clinical Milestones; Poised for Value-Defining First-in-Human Lens Implantations
Calgary, Alberta – TheNewswire - August 12, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is ple...
Ocumetics Begins Patient Recruitment for First-In-Human Clinical Study of Accommodating Intraocular Lens
Calgary, Alberta – TheNewswire - August 5, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is plea...
Ocumetics Receives Ethics Committee Approval for First-In-Human Clinical Study of Accommodating Intraocular Lens
Calgary, Alberta – TheNewswire - July 30, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleas...
Ocumetics Announces Completion of First Tranche of Unit Private Placement
Calgary, Alberta – TheNewswire - July 17, 2025 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the first tra...